ArticleClinical case reports2026
Enhancing Surgical Decision-Making for Infected Cardiac Device Lead Removal With 18F-FDG PET/CT: A Case Study and Literature Analysis.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhancing Surgical Decision-Making for Infected Cardiac Device Lead Removal With 18F-FDG PET/CT: A Case Study and Literature Analysis.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Residual implantable cardiac electronic device (ICED) leads pose a significant infection risk, necessitating a multimodal diagnostic and therapeutic approach. This case highlights the critical role of PET/CT imaging in guiding surgical decision-making, particularly in cases of chronic infections with embedded or fractured lead fragments. While percutaneous extraction may be incomplete, surgical intervention under cardiopulmonary bypass is often required for definitive management. Early identification of residual infected material is essential to prevent recurrent sepsis and optimize patient outcomes. A comprehensive strategy integrating advanced imaging, targeted antimicrobial therapy, and surgical expertise is key to successfully managing complex ICED-related infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.